Home Cart Sign in  
Chemical Structure| 5875-06-9 Chemical Structure| 5875-06-9

Structure of Proparacaine HCl
CAS No.: 5875-06-9

Chemical Structure| 5875-06-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Proparacaine HCl is an antagonist of voltage-gated sodium channels with ED50 of 3.4 mM.

Synonyms: Proxymetacaine Hydrochloride; Proparacaine HCl; Parcaine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Proparacaine HCl

CAS No. :5875-06-9
Formula : C16H27ClN2O3
M.W : 330.85
SMILES Code : O=C(OCCN(CC)CC)C1=CC=C(OCCC)C(N)=C1.[H]Cl
Synonyms :
Proxymetacaine Hydrochloride; Proparacaine HCl; Parcaine
MDL No. :MFCD00083467
InChI Key :BFUUJUGQJUTPAF-UHFFFAOYSA-N
Pubchem ID :517321

Safety of Proparacaine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H317-H332
Precautionary Statements:P280

Isoform Comparison

Biological Activity

Target
  • Sodium Channel

    Voltage-gated sodium channel, ED50:3.4 mM

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Diabetic OLETF rats and non-diabetic LETO rats Topical application to the eye 0.5% Single dose Anesthetize rats for intravitreal injection PMC2494683
New Zealand albino rabbits Anesthetized rabbit model Topical ocular application 0.5%, 10 μL Single dose, measurements continued for 5 to 15 minutes To determine the effect of proparacaine on episcleral venous pressure (EVP). Results showed a significant decrease in EVP (from 12.3 ± 1.1 mm Hg to 8.7 ± 0.9 mm Hg) and a small decrease in intraocular pressure (IOP). PMC4572517
New Zealand White rabbits Normal rabbit eye model Topical ocular administration 0.5% Single dose or administered 10 minutes before tear collection To evaluate the effect of anesthesia on basal tear secretion, results showed optimal anesthesia at 10 minutes, effectively suppressing reflex tearing. PMC3176019
BALB/c mice Allergic rhinitis model Intranasal administration 75 μg/30 μL 7 consecutive days PPC significantly decreased nasal symptoms, number of eosinophils, goblet cells, and mast cells in the lamina propria of the nasal mucosa. Serum OVA-specific IgE, OVA-specific IgG1, and OVA-specific IgG2a levels were significantly higher in the AR group compared to the control group, but no significant difference was observed between the PPC and AR groups. Serum IL-4 levels were significantly lower in the PPC group compared to the AR group, while IL-5 levels showed no significant difference among all groups. No significant difference in serum cortisol levels was observed among the four groups. PMC5678040

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.02mL

0.60mL

0.30mL

15.11mL

3.02mL

1.51mL

30.23mL

6.05mL

3.02mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories